Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (Pyridin-2-yl)amine derivatives as TGF-BETA R1 (ALK5) inhibitors for the treatment of cancer

(Pyridin-2-yl)amine derivatives as TGF-BETA R1 (ALK5) inhibitors for the treatment of cancer

US Patent 12102626 · Granted Oct 1, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

One step synthesis for alkyl 2-fluoroacrylates2025
Aryl hydrocarbon receptor agonists and uses thereof2025
Aryl hydrocarbon receptor agonists and uses thereof2025
Safe box2025
Aryl hydrocarbon receptor agonists and uses thereof2024
Aryl hydrocarbon receptor agonists and uses thereof2024
Compounds and compositions for treating solid tumors by intratumoral administrat2023
6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors2022
Substituted pyrimidines containing acidic groups as TLR7 modulators2021
Antibody conjugates comprising toll-like receptor agonist2021
Pyrimidine compounds containing acidic groups2020
Compounds and compositions as toll-like receptor 7 agonists2020